Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort.

Foubert-Samier A, Helmer C, Perez F, Le Goff M, Auriacombe S, Elbaz A, Dartigues JF, Tison F.

Neurology. 2012 Oct 9;79(15):1615-21. doi: 10.1212/WNL.0b013e31826e25ce. Epub 2012 Sep 26.

PMID:
23019267
[PubMed - indexed for MEDLINE]
2.

Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study.

Caslake R, Taylor K, Scott N, Gordon J, Harris C, Wilde K, Murray A, Counsell C.

Parkinsonism Relat Disord. 2013 May;19(5):515-21. doi: 10.1016/j.parkreldis.2013.01.014. Epub 2013 Feb 23. Review.

PMID:
23462482
[PubMed - indexed for MEDLINE]
3.

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.

Friedman JH, Factor SA.

Mov Disord. 2000 Mar;15(2):201-11. Review.

PMID:
10752567
[PubMed - indexed for MEDLINE]
4.

Parkinson disease in the elderly adult.

Willis AW.

Mo Med. 2013 Sep-Oct;110(5):406-10. Review.

PMID:
24279192
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk